Paul Tudor Jones Nevro Corp Transaction History

Tudor Investment Corp Et Al

$26.8 Billion
Q3 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Nevro Corp stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 130,158 shares of NVRO stock, worth $516,727. This represents 0.0% of its overall portfolio holdings.

Number of Shares

130,158

Previous 126,006 3.3%

Holding current value

$516,727

Previous $1.06 Million 31.51%

% of portfolio

0.0%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$4.71 - $10.1 $19,555 - $41,935	4,152 Added 3.3%	130,158 $726,000
Q2 2024 Aug 14, 2024	SELL	$7.96 - $13.59 $16,222 - $27,696	-2,038 Reduced 1.59%	126,006 $1.06 Million
Q1 2024 May 15, 2024	BUY	$13.56 - $20.78 $542,752 - $831,740	40,026 Added 45.47%	128,044 $1.85 Million
Q4 2023 Feb 14, 2024	BUY	$14.18 - $22.31 $222,441 - $349,976	15,687 Added 21.69%	88,018 $1.89 Million
Q3 2023 Nov 15, 2023	SELL	$18.22 - $25.85 $445,315 - $631,799	-24,441 Reduced 25.26%	72,331 $1.39 Million
Q2 2023 Aug 14, 2023	BUY	$22.62 - $39.32 $1.02 Million - $1.77 Million	44,933 Added 86.68%	96,772 $2.46 Million
Q1 2023 May 15, 2023	SELL	$30.17 - $41.11 $529,272 - $721,192	-17,543 Reduced 25.28%	51,839 $1.87 Million
Q4 2022 Feb 14, 2023	BUY	$36.43 - $49.4 $2.53 Million - $3.43 Million	69,382 New	69,382 $2.75 Million
Q2 2022 Aug 15, 2022	SELL	$40.85 - $77.67 $1.02 Million - $1.94 Million	-24,986 Reduced 83.91%	4,790 $210,000
Q1 2022 May 16, 2022	BUY	$59.95 - $92.06 $954,943 - $1.47 Million	15,929 Added 115.04%	29,776 $2.15 Million
Q4 2021 Feb 14, 2022	BUY	$81.07 - $121.29 $1.12 Million - $1.68 Million	13,847 New	13,847 $1.12 Million
Q3 2021 Nov 15, 2021	SELL	$101.99 - $166.36 $143,907 - $234,733	-1,411 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$141.6 - $179.06 $199,797 - $252,653	1,411 New	1,411 $234,000
Q1 2021 May 17, 2021	SELL	$132.81 - $182.18 $1.12 Million - $1.53 Million	-8,411 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$138.17 - $184.34 $956,136 - $1.28 Million	6,920 Added 464.12%	8,411 $1.46 Million
Q3 2020 Nov 16, 2020	SELL	$114.09 - $145.51 $1.01 Million - $1.28 Million	-8,822 Reduced 85.54%	1,491 $208,000
Q2 2020 Aug 14, 2020	BUY	$89.45 - $129.85 $260,657 - $378,382	2,914 Added 39.38%	10,313 $1.23 Million
Q1 2020 May 15, 2020	BUY	$70.23 - $144.31 $381,559 - $784,036	5,433 Added 276.35%	7,399 $740,000
Q4 2019 Feb 14, 2020	BUY	$76.41 - $117.54 $150,222 - $231,083	1,966 New	1,966 $231,000
Q1 2019 May 15, 2019	SELL	$35.52 - $62.62 $612,222 - $1.08 Million	-17,236 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$35.43 - $56.29 $46,413 - $73,739	1,310 Added 8.23%	17,236 $670,000
Q3 2018 Nov 14, 2018	BUY	$44.22 - $75.47 $422,920 - $721,795	9,564 Added 150.33%	15,926 $908,000
Q2 2018 Aug 14, 2018	BUY	$72.38 - $92.5 $29,024 - $37,092	401 Added 6.73%	6,362 $508,000
Q1 2018 May 15, 2018	BUY	$69.46 - $88.57 $208,588 - $265,975	3,003 Added 101.52%	5,961 $517,000
Q4 2017 Feb 14, 2018	BUY	$65.94 - $93.31 $195,050 - $276,010	2,958	2,958 $204,000

Others Institutions Holding NVRO

# of Institutions

151

Shares Held

39.3M

Call Options Held

67.9K

Put Options Held

1.59M

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $140M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account